Discontinuation of antidepressants during attempts to conceive: A pilot trial of cognitive behavioral therapy for the prevention of recurrent depression

Journal of Clinical Psychopharmacology

Volumn 34, Issue 4, 2014, Pages 455-460

  Psaros, Christina ^a,b,c   Freeman, Marlene ^a,b   Safren, Steven A ^b,c   Barsky, Maria ^a   Cohen, Lee S ^a,b  

^a Center for Women's Mental Health   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

antidepressants; behavior therapy; CBT; depression; pregnancy

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COGNITIVE THERAPY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR DEPRESSION; MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PILOT STUDY; PREGNANCY; PRIORITY JOURNAL; RATING SCALE; RECURRENT DISEASE; DEPRESSIVE DISORDER, MAJOR; DRUG EFFECTS; FERTILIZATION; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; TRENDS;

ANTIDEPRESSANT AGENT;

ADULT; ANTIDEPRESSIVE AGENTS; COGNITIVE THERAPY; DEPRESSIVE DISORDER, MAJOR; FEMALE; FERTILIZATION; FOLLOW-UP STUDIES; HUMANS; PILOT PROJECTS; PREGNANCY; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; TREATMENT OUTCOME; WITHHOLDING TREATMENT;

EID: 84903760970     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0000000000000158     Document Type: Article

References (40)

1. Marcus S, Flynn H, Blow F, et al. Depressive symptoms among pregnant women screened in obstetrics settings. J Women Health (Larchmt). 2003;12:373-380. (Pubitemid 36701614)
2. Oberlander TF, Warburton W, Misri S, et al. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry. 2006;63:898-906. (Pubitemid 44188483)
3. Altshuler LL, Cohen LS, Moline ML, et al. The Expert Consensus Guideline Series. Treatment of depression in women. Postgrad Med. 2001(Spec No):1-107.
4. Zuckerman BS, Amaro H, Bauchner H, et al. Depression during pregnancy: relationship to prior health behaviors. Am J Obstet Gynecol. 1989;160:1107-1111. (Pubitemid 19144468)
5. Ahluwalia IB, Mack KA, Mokdad A. Mental and physical distress and high-risk behaviors among reproductive-age women. Obstet Gynecol. 2004;104:477-483. (Pubitemid 40458832)
6. O'Hara MW, Schlechte JA, Lewis DA, et al. Controlled prospective of postpartum mood disorders: psychological, environmental, and hormonal variables. J Abnorm Psychol. 1991;100:63-73.
7. Cohen LS, Altshuler LL, Harlow BL, et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA. 2006;295:499-507. (Pubitemid 43200344)
8. Einarson A, Selby P, Koren G. Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counseling. J Psychiatry Neurosci. 2001;26:44-48. (Pubitemid 32185179)
9. Anderson IM, Nutt DJ, Deakin JF. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology. J Psychopharmacol. 2000;14:3-20. (Pubitemid 30156533)
10. Keller MB. Long-term treatment of recurrent and chronic depression. J Clin Psychiatry. 2001;62(Suppl 24):3-5. (Pubitemid 32954949)
11. Dunner DL. Acute and maintenance treatment of chronic depression. J Clin Psychiatry. 2001;62(Suppl 6):10-16. (Pubitemid 32298432)
12. Alwan S, Reefhuis J, Rasmussen SA, et al. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med. 2007;356:2684-2692. (Pubitemid 47001036)
13. Louik C, Lin AE, Werler MM, et al. First-trimester use of selective serotonin reuptake inhibitors and the risk of birth defects. N Engl J Med. 2007;356:2675-2683. (Pubitemid 47001035)
14. Cohen LS, Heller VL, Bailey JW, et al. Birth outcomes following prenatal exposure to fluoxetine. Biol Psychiatry. 2000;48:996-1000.
15. Oberlander TF, Misri S, Fitzgerald RN, et al. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. J Clin Psychiatry. 2004;65: 230-237.
16. Einarson A, Fatoye B, Sarkar M, et al. Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study. Am J Psychiatry. 2001;158:1728-1730. (Pubitemid 32923672)
17. Costei AM, Kozer E, Ho T, et al. Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med. 2002;156:1129-1132. (Pubitemid 36343460)
18. Chambers CD, Hernandez-Diaz S, Van Marter LJ, et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med. 2006;354:579-587. (Pubitemid 43209105)
19. Croen LA, Grether JK, Yoshida CK, et al. Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch Gen Psychiatry. 2011;68:1104-1112.
20. Mulder EJ, Ververs FF, de Heus R, et al. Selective serotonin reuptake inhibitors affect neurobehavioral development in the human fetus. Neuropsychopharmacology. 2011;36:1961-1971.
21. Figueroa R. Use of antidepressants during pregnancy and risk of attention-deficit/hyperactivity disorder in the offspring. J Dev Behav Pediatr. 2010;31:641-648.
22. DeRubeis RJ, Gelfand LA, Tang TZ, et al. Medications versus cognitive behavior therapy for severely depressed outpatients: mega-analysis of four randomized comparisons. Am J Psychiatry. 1999;156:1007-1013. (Pubitemid 29302791)
23. Gloaguen V, Cottraux J, Cucherat M, et al. A meta-analysis of the effects of cognitive therapy in depressed patients. J Affect Disord. 1998;49:59-72. (Pubitemid 28139098)
24. Wampold BE, Minami T, Baskin TW, et al. A meta-(re)analysis of the effects of cognitive therapy versus 'other therapies' for depression. J Affect Disord. 2002;68:159-165.
25. Ma SH, Teasdale JD. Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects. J Consult Clin Psychol. 2004;72:31-40. (Pubitemid 38380527)
26. Jarrett RB, Kraft D, Doyle J, et al. Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomized clinical trial. Arch Gen Psychiatry. 2001;58:381-388. (Pubitemid 32299534)
27. Paykel ES, Scott J, Teasdale JD, et al. Prevention of relapse in residual depression by cognitive therapy: a controlled trial. Arch Gen Psychiatry. 1999;56:829-835. (Pubitemid 29420704)
28. Fava GA, Rafanelli C, Grandi S, et al. Prevention of recurrent depression with cognitive behavioral therapy: preliminary findings. Arch Gen Psychiatry. 1998;55:816-820. (Pubitemid 28413044)
29. Fava GA, Rafanelli C, Grandi S, et al. Six-year outcome for cognitive behavioral treatment of residual symptoms in major depression. Am J Psychiatry. 1998;155:1443-1445. (Pubitemid 28471205)
30. Fava GA, Ruini C, Rafanelli C, et al. Cognitive behavior approach to loss of clinical effect during long-term antidepressant treatment: a pilot study. Am J Psychiatry. 2002;159:2094-2095. (Pubitemid 35423871)
31. Le HN, Perry DF, Stuart EA. Randomized controlled trial of a preventive intervention for perinatal depression in high-risk Latinas. J Consult Clin Psychol. 2011;79:135-141.
32. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22-33. (Pubitemid 29001829)
33. Montgomery SA, Å sberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389. (Pubitemid 9136500)
34. Endicott J, Nee J, Harrison W, et al. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull. 1993;29:321-326. (Pubitemid 23311543)
35. National Institute of Mental Health. CGI: Clinical Global Impression ScaleVNIMH. Psychopharmacol Bull. 1985;21:839-844.
36. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
37. Barlow DH, ed. Clinical Handbook of Psychological Disorders: A Step-by-step Treatment Manual. 4th ed. New York, NY: The Guilford Press; 2008.
38. Schechter D, Endicott J, Nee J. Quality of life of 'normal' controls: association with lifetime history of mental illness. Psychiatry Res. 2007;152:45-54. (Pubitemid 47030679)
39. Domar A, Broome A, Zuttermeister P, et al. The prevalence and predictability of depression in infertile women. Fertil Steril. 1992;58:1158-1163. (Pubitemid 23001288)
40. Burns LH. Psychiatric aspects of infertility and infertility treatments. Psychiatr Clin North Am. 2007;30:689-716. (Pubitemid 47552657)